The Discounted Cash Flow (DCF) valuation of Genmark Diagnostics Inc (GNMK) is 0.12 USD. With the latest stock price at 24.04 USD, the upside of Genmark Diagnostics Inc based on DCF is -99.5%.
Based on the latest price of 24.04 USD and our DCF valuation, Genmark Diagnostics Inc (GNMK) is a sell. selling GNMK stocks now will result in a potential gain of 99.5%.
| Range | Selected | |
| WACC / Discount Rate | 6.6% - 8.8% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (0.24) - 1.44 | 0.12 |
| Upside | -101.0% - -94.0% | -99.5% |